|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
HIV Infection and AIDS
(Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome)
by Rick Alan
Human immunodeficiency virus (HIV) is a viral infection. It attacks white blood cells called T-cells (CD4). They help the body fight infections and diseases. If you have HIV, it can leave you at risk for many health problems.
AIDS is a late stage of HIV. Immune system damage from HIV allows opportunistic infections (OIs) to take hold in the body.
HIV-1 or HIV-2 viruses cause infection. HIV spreads between people from direct contact with fluids from the body of someone who has it. This means blood, semen, vaginal fluid, and breast milk.
HIV destroys T-cells, leading to AIDS.
You can get HIV by:
Rarely, HIV spreads by:
A mother can pass HIV to her child during pregnancy, birth, or breastfeeding.
Risk Factors TOP
Your chances of HIV are higher if you:
Having HIV is the only risk factor for developing AIDS.
HIV may not cause problems for a number of years. Early symptoms may appear 1-2 months after infection. They’re similar to the flu:
The symptoms will pass on their own, but the virus remains. You may not have problems for months to years. Over time, it’s harder to fight infections. Many symptoms on the list above come back. In addition, you may notice:
Without care, HIV infection progresses to AIDS. People with AIDS are at high risk for OIs that happen anywhere in the body. AIDs may cause:
The doctor will ask about your symptoms. You will also be asked about your health and sexual history. Your answers and a physical exam may point to HIV. You may also have:
Medicines can prevent or slow progression to AIDS in many people. A combination of antiviral medicines are often used. These may include:
Medicines help fight or stop OIs for those with AIDS. These may include antibiotics or antifungal medicines.
To lower your chances of HIV:
If you work with people or are in a household where HIV is present:
If you have HIV:
AMFAR—The Foundation for AIDS Research
Centers for Disease Control and Prevention
AIDS Committee of Toronto
Canadian AIDS Society
2015 Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention website. Available at:
...(Click grey area to select URL)
Updated January 25, 2017. Accessed May 30, 2018.
Acute HIV infection. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T902526/Acute-HIV-infection. Updated October 26, 2016. Accessed May 30, 2018.
Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet. 2007;369(9562):643-656.
Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657-666.
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. AIDS Info website. Available at: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Updated March 27, 2018. Accessed May 30, 2018.
HIV/AIDS. Centers for Disease Control and Prevention website. Available at: https://www.cdc.gov/hiv. Updated May 29, 2018. Accessed May 30, 2018.
HIV/AIDS: The basics. AIDS info website. Available at: https://aidsinfo.nih.gov/education-materials/fact-sheets/19/45/hiv-aids--the-basics. Updated August 22, 2017. Accessed May 30, 2018.
HIV diagnostic testing. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T902526/Acute-HIV-infection. Updated September 26, 2017. Accessed May 30, 2018.
Montaner JS. Treatment as prevention: A double hat-trick. Lancet. 2011;378(9787):208-209.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Centers for Disease Control and Prevention website. Available at: https://www.cdc.gov/nchhstp/Default.htm. Updated May 21, 2018. Accessed May 30, 2018.
Overview of HIV infection. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated May 8, 2018. Accessed May 30, 2018.
Pre-exposure prophylaxis (PrEP). AIDS website. Available at: https://www.hiv.gov/hiv-basics/hiv-prevention/using-hiv-medication-to-reduce-risk/pre-exposure-prophylaxis. Accessed May 30, 2018.
Preventing transmission of HIV. AIDS info website. Available at: https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/20/48/the-basics-of-hiv-prevention. Updated May 24, 2018. Accessed May 30, 2018.
Rey D, Krebs M, Partisani M, Hess G, et al. Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients. J Acquir Immune Defic Syndr. 2006;43(5): 530-534.
Ross LL, Parkin N, Gerondelis P, et al. Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility. J Acquir Immune Defic Syndr. 2006;43(5):567-570.
Last reviewed May 2018 by EBSCO Medical Review Board David L. Horn, MD, FACP
Last Updated: 5/29/2018
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.